Researchers have developed innovative mRNA vaccines expanding beyond infectious diseases. A novel intramuscular mRNA vaccine delivering LRG1 protein mRNA inhibited pathological neovascularization in mouse models of age-related macular degeneration, marking progress toward less invasive treatments for eye diseases. Another mRNA vaccine engineered to prevent dangerous allergic reactions shows potential to treat food and seasonal allergies, broadening the therapeutic scope of mRNA technology.